Cargando…
Anti-leukemic properties of deferasirox via apoptosis in murine leukemia cell lines
BACKGROUND: Although deferasirox (DFX) is reported to have anti-tumor effects, its anti-leukemic activity remains unclear. We evaluated the effect of DFX treatment on two murine lymphoid leukemia cell lines, and clarified the mechanisms underlying its potential anti-leukemic activity. METHODS: L1210...
Autores principales: | Jeon, Sol-Rim, Lee, Jae-Wook, Jang, Pil-Sang, Chung, Nack-Gyun, Cho, Bin, Jeong, Dae-Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377336/ https://www.ncbi.nlm.nih.gov/pubmed/25830128 http://dx.doi.org/10.5045/br.2015.50.1.33 |
Ejemplares similares
-
Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia
por: Oh, Hyun Jin, et al.
Publicado: (2013) -
Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia
por: Lee, Jae Wook, et al.
Publicado: (2021) -
Rapid resolution of bone marrow necrosis mimicking relapse of pediatric acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2020) -
Outcome and Prognostic Factors for ETV6/RUNX1 Positive Pediatric Acute Lymphoblastic Leukemia Treated at a Single Institution in Korea
por: Lee, Jae Wook, et al.
Publicado: (2017) -
Outcome of Intensive Therapy for Children with Relapsed Acute Myeloid Leukemia: A Single Institution Korean Study
por: Lee, Jae Wook, et al.
Publicado: (2022)